Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
M402 in Combination With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer
This study is currently recruiting participants.
Verified May 2013
by Momenta Pharmaceuticals, Inc.
Study NCT01621243 Information provided by Momenta Pharmaceuticals, Inc.
First Received on May 22, 2012. Last Updated on May 9, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Metastatic Pancreatic Cancer
Additional conditions recognized in this trial
More general conditions related to this trial
Digestive System Diseases
Digestive System Neoplasms
Endocrine Gland Neoplasms
Endocrine System Diseases
Neoplasms by Site
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Antineoplastic Agents, Phytogenic
Fibrin Modulating Agents
Molecular Mechanisms of Pharmacological Action
Physiological Effects of Drugs
Sponsors listed in this trial
Momenta Pharmaceuticals, Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers